Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Variation in behavioral engagement during an active learning activity leads to differential knowledge gains in college students.

LaDage LD, Tornello SL, Vallejera JM, Baker EE, Yan Y, Chowdhury A.

Adv Physiol Educ. 2018 Mar 1;42(1):99-103. doi: 10.1152/advan.00150.2017.

2.

Finding key words in a question stem.

Crestodina L, Baker EE, Durkop-Scott KL.

J Wound Ostomy Continence Nurs. 2013 Nov-Dec;40(6):639-40. doi: 10.1097/01.WON.0000436429.33090.4d. No abstract available.

PMID:
24202228
3.

Proliferative Activity in Pancreatic Endocrine Tumors: Association with Function, Metastases, and Survival.

Clarke MR, Baker EE, Weyant RJ, Hill L, Carty SE.

Endocr Pathol. 1997 Autumn;8(3):181-187.

PMID:
12114721
4.

Are you listening, doctor?

Baker EE Jr.

N Y J Dent. 1984 Jun-Aug;54(5):201-2. No abstract available.

PMID:
6589545
5.

My philosophy on aging.

Baker EE.

N J Nurse. 1980 Jan-Feb;10(1):3. No abstract available.

PMID:
6928594
6.

Avermectins, new family of potent anthelmintic agents: producing organism and fermentation.

Burg RW, Miller BM, Baker EE, Birnbaum J, Currie SA, Hartman R, Kong YL, Monaghan RL, Olson G, Putter I, Tunac JB, Wallick H, Stapley EO, Oiwa R, Omura S.

Antimicrob Agents Chemother. 1979 Mar;15(3):361-7.

7.

A new iron-containing superoxide dismutase from Escherichia coli.

Dougherty HW, Sadowski SJ, Baker EE.

J Biol Chem. 1978 Jul 25;253(14):5220-3.

8.

Marrow-dependent cell function in early stages of infection with Listeria monocytogenes.

Bennett M, Baker EE.

Cell Immunol. 1977 Sep;33(1):203-10. No abstract available.

PMID:
198147
9.

Selective elimination of marrow precursors with the bone-seeking isotope 89Sr: implications for hemopoiesis, lymphopoiesis, viral leukemogenesis and infection.

Bennett M, Baker EE, Eastcott JW, Kumar V, Yonkosky D.

J Reticuloendothel Soc. 1976 Jul;20(1):71-87. No abstract available.

PMID:
781225
10.

Common enterobacterial antigen. I. Isolation and purification from Salmonella typhose 0:901.

Johns MA, Whiteside RE, Baker EE, McCabe WR.

J Immunol. 1973 Mar;110(3):781-90. No abstract available.

PMID:
4631872
11.

Role of O-acetyl groups in the interaction of Vi antigen with protein.

McNicol LA, Baker EE.

Biochim Biophys Acta. 1971 Jan 19;229(1):233-9. No abstract available.

PMID:
5101162
12.

Pectate lyase and polygalacturonate lyase activity in a Vi antigen-degrading enzyme preparation.

McNicol LA, Baker EE.

Biochemistry. 1970 Feb 17;9(4):1017-23. No abstract available.

PMID:
4984727
13.

Interaction of Vi antigen with proteins.

Whiteside RE, Baker EE.

J Bacteriol. 1966 Dec;92(6):1597-603.

14.

SIGNIFICANCE OF SALMONELLAE ISOLATED FROM APPARENTLY HEALTHY MICE.

MORELLO JA, DIGENIO TA, BAKER EE.

J Bacteriol. 1965 Jun;89:1460-4.

15.

PREPARATION AND PROPERTIES OF A VI ANTIGEN-DEGRADING ENZYME.

BAKER EE, WHITESIDE RE.

J Bacteriol. 1965 May;89:1217-24.

16.

INTERACTION OF SALMONELLA WITH PHAGOCYTES IN VITRO.

MORELLO JA, BAKER EE.

J Infect Dis. 1965 Apr;115:131-41. No abstract available.

PMID:
14308360
17.
18.

CLOSTRIDIAL INFECTIONS WITH SPECIAL REFERENCE TO CLOSTRIDIUM PERFRINGENS.

BAKER EE.

Am J Surg. 1964 May;107:689-92. No abstract available.

PMID:
14166201
19.

Inhibition with simple sugars of hemagglutination of red cells modified with Salmonella antigens.

TRUSZCZYNSKI M, BAKER EE.

J Immunol. 1962 Jul;89:154-9. No abstract available.

PMID:
13922726
20.

Antigenic analysis of Salmonella typhosa and related salmonellas.

WHITESIDE RE, BAKER EE.

J Immunol. 1962 May;88:650-60. No abstract available.

PMID:
14006613
21.

Linkage between 9 and 12 antigens of Salmonella typhosa.

WHITESIDE RE, TAKEI T, BAKER EE.

Proc Soc Exp Biol Med. 1962 Mar;109:619-22. No abstract available.

PMID:
14006614
22.

The Vi antigens of the Enterobacteriaceae. V. Serologic differences of Vi antigens revealed by deacetylation.

WHITESIDE RE, BAKER EE.

J Immunol. 1961 May;86:538-42. No abstract available.

PMID:
13784897
23.

Vi antigens of the Enterobacteriaceae. IV. Purification and properties of Vi antigen of S. paratyphi C.

BAKER EE, WHITESIDE RE.

Proc Soc Exp Biol Med. 1960 Nov;105:328-30. No abstract available.

PMID:
13686097
24.
25.

The VI antigens of the Enterobacteriaceae. I. Purification and chemical properties.

BAKER EE, WHITESIDE RE, BASCH R, DEROW MA.

J Immunol. 1959 Dec;83:680-96. No abstract available.

PMID:
13795984
26.

The immune response of the guinea pig to the antigens of Pasteurella pestis.

SPIVACK ML, FOSTER L, LARSON A, CHEN TH, BAKER EE, MEYER KF.

J Immunol. 1958 Feb;80(2):132-41. No abstract available.

PMID:
13514082
27.

Effect of antimetabolites on growth of Endamoeba histolytica. II. Pantetheine and coenzyme A antagonist.

BAKER EE, NAKAMURA M.

Proc Soc Exp Biol Med. 1956 Aug-Sep;92(4):723-5. No abstract available.

PMID:
13370507
28.

Nutritional requirements of Endamoeba histolytica.

NAKAMURA M, BAKER EE.

Am J Hyg. 1956 Jul;64(1):12-22. No abstract available.

PMID:
13339774
29.

Serologic relationships of Escherichia coli isolated before and after treatment with chlortetracycline.

POWERS D, BAKER EE.

Antibiotic Med Clin Ther (New York). 1955 Oct;1(10):570-6. No abstract available.

PMID:
13259485
30.

Changes in coliform flora of human feces following oral administration of chlortetracycline.

THOMAS EE, BAKER EE.

Antibiotic Med Clin Ther (New York). 1955 Oct;1(10):545-54. No abstract available.

PMID:
13259481
31.

Fecal flora of man after oral administration of chlortetracycline or oxytetracycline.

LOH WP, BAKER EE.

AMA Arch Intern Med. 1955 Jan;95(1):74-82. No abstract available.

PMID:
13217506
32.

Alteration in fecal flora of man following oral aureomycin or terramycin.

LOH WP, BAKER EE.

BMQ. 1953 Sep;4(3):87-99. No abstract available.

PMID:
13093567
33.

Quantitative studies of cross reactions between Shigella flexneri types 1a, 1b, and 31.

FORMAL SB, BAKER EE.

J Immunol. 1953 Mar;70(3):260-6. No abstract available.

PMID:
13035116
34.

Teaching aphasic patients to talk again.

BAKER EE, SOKOLOFF M.

Am J Nurs. 1952 Jul;52(7):831-2. No abstract available.

PMID:
12976450
35.

Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of Pasteurella pestis.

BAKER EE, SOMMER H, FOSTER LE, MEYER E, MEYER KF.

J Immunol. 1952 Feb;68(2):131-45. No abstract available.

PMID:
14927919
36.

Therapy for speech deficiencies resulting from acute bulbar poliomyelitis infection.

BAKER EE Jr, SOKOLOFF MA.

J Speech Disord. 1951 Dec;16(4):337-9. No abstract available.

PMID:
14881196
37.

The specific antigens of variants of Shigella sonnei.

BAKER EE, GOEBEL WF, PERLMAN E.

J Exp Med. 1949 Mar;89(3):325-38.

38.

The isolation and properties of specific antigens from variants of Shigella sonnei.

BAKER EE, PERLMAN E, GOEBEL WF.

Fed Proc. 1948 Mar;7(1 Pt 1):301. No abstract available.

PMID:
18932531
39.

Antigenic structure of Pasteurella pestis and the isolation of a crystalline antigen.

BAKER EE, SOMMER H, et al.

Proc Soc Exp Biol Med. 1947 Feb;64(2):139-41. No abstract available.

PMID:
20287358

Supplemental Content

Loading ...
Support Center